Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_2
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

terminated125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis

NCT03312140
terminatedphase_2

Total Parenteral Nutrition-Associated Liver Disease

NCT00031135
completednot_applicable

Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition

NCT00004697
completednot_applicable

Effect of Maternal Choline Intake on Choline Status and Health Biomarkers During Pregnancy and Lactation

NCT01127022

Clinical Trials (4)

Showing 4 of 4 trials
NCT03312140Not Applicable

Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis

Completed
NCT00031135Phase 2

Total Parenteral Nutrition-Associated Liver Disease

Terminated
NCT00004697Not Applicable

Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition

Completed
NCT01127022Not Applicable

Effect of Maternal Choline Intake on Choline Status and Health Biomarkers During Pregnancy and Lactation

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4